(Q50422607)

English

SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma.

scientific article published on 14 February 2018

Statements

SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit